Testing for colorectal cancer: a focus on FIT technology

Quantitative faecal immunochemical testing looks set to reassure patients and clinicians concerned about colorectal cancer. Reducing referrals, colonoscopy investigations and overall waiting times, FIT enables GPs to manage patients confidently in primary care.

This story is Premium Content and is only available to registered users. Please log in to view the full text. If you don't already have an account, please register with us completely free of charge.